Clinical trial
Clinical Investigation of a DES (MiStent™ System) With Sirolimus and a Bioabsorbable Polymer for the Treatment of Patients With De Novo Lesions in Native Coronary Arteries.
NCT01294748 is registered in ClinicalTrials.gov with Micell Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Investigation of a DES (MiStent™ System) With Sirolimus and a Bioabsorbable Polymer for the Treatment of Patients With De Novo Lesions in Native Coronary Arteries.
- Lead sponsor
- Micell Technologies
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- August 31, 2016
- Enrollment
- 184 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.